CytoMed Therapeutics (GDTC) Stock: Why It Fell
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.85, -3.18% vs the prior close of $0.88.
- Volume 15.00K shares, 0.8x its 50-day average.
- New SEC filings: SCHEDULE 13D/A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)
GDTC slides 3.2% to $0.85. Closed at $0.85, -3.18% vs the prior close of $0.88. Day range $0.84–$0.87, opened at $0.87.
GDTC daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — GDTC slides 3.2% to $0.85
- Closed at $0.85, -3.18% vs the prior close of $0.88. Day range $0.84–$0.87, opened at $0.87.
- Volume was 15.10K shares, 0.8x its 50-day average of 18.63K.
- Price is -5.0% vs its 50-day average ($0.90) and -14.4% vs its 200-day average ($1.00).
- 52-week range $0.68–$3.68; today's close sits at 6% of that range, 76.8% below the 52-week high.
Oct 16, 2026 — GDTC rises 1.1% to $0.88
- Closed at $0.88, +1.14% vs the prior close of $0.87. Day range $0.84–$0.94, opened at $0.94.
- Volume was 7.26K shares, 0.3x its 50-day average of 21.00K — lighter than usual.
- Price is -1.9% vs its 50-day average ($0.90) and -11.8% vs its 200-day average ($1.00).
- 52-week range $0.68–$3.68; today's close sits at 7% of that range, 76.1% below the 52-week high.
Oct 15, 2026 — GDTC rises 1.2% to $0.87
- Closed at $0.87, +1.16% vs the prior close of $0.86. Day range $0.73–$0.88, opened at $0.81.
- Volume was 9.50K shares, 0.4x its 50-day average of 21.41K — lighter than usual.
- Price is -2.8% vs its 50-day average ($0.90) and -13.0% vs its 200-day average ($1.00).
- 52-week range $0.68–$3.68; today's close sits at 6% of that range, 76.4% below the 52-week high.
Oct 14, 2026 — GDTC dips 1.1% to $0.86
- Closed at $0.86, -1.15% vs the prior close of $0.87. Day range $0.81–$0.87, opened at $0.83.
- Volume was 10.60K shares, 0.5x its 50-day average of 21.45K — lighter than usual.
- Price is -3.8% vs its 50-day average ($0.89) and -14.3% vs its 200-day average ($1.00).
- 52-week range $0.68–$3.68; today's close sits at 6% of that range, 76.6% below the 52-week high.
Oct 13, 2026 — GDTC jumps 7.3% to $0.87
- Closed at $0.87, +7.27% vs the prior close of $0.81. Day range $0.81–$0.88, opened at $0.87.
- Volume was 24.00K shares, 1.1x its 50-day average of 21.09K.
- Price is -2.7% vs its 50-day average ($0.89) and -13.6% vs its 200-day average ($1.01).
- 52-week range $0.68–$3.68; today's close sits at 6% of that range, 76.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — GDTC slides 8.9% to $0.81 on 2.7x normal volume
- Closed at $0.81, -8.88% vs the prior close of $0.89. Day range $0.71–$0.98, opened at $0.84.
- Volume was 54.80K shares, 2.7x its 50-day average of 20.53K — unusually heavy trading.
- Price is -9.4% vs its 50-day average ($0.90) and -19.7% vs its 200-day average ($1.01).
- 52-week range $0.68–$3.68; today's close sits at 4% of that range, 78.0% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — GDTC slides 5.8% to $0.89
- Closed at $0.89, -5.82% vs the prior close of $0.94. Day range $0.85–$0.94, opened at $0.94.
- Volume was 11.80K shares, 0.6x its 50-day average of 20.48K — lighter than usual.
- Price is -0.8% vs its 50-day average ($0.90) and -12.2% vs its 200-day average ($1.01).
- 52-week range $0.68–$3.68; today's close sits at 7% of that range, 75.8% below the 52-week high.
Oct 8, 2026 — GDTC slides 3.6% to $0.94
- Closed at $0.94, -3.57% vs the prior close of $0.98. Day range $0.90–$0.94, opened at $0.90.
- Volume was 23.20K shares, 1.1x its 50-day average of 20.39K.
- Price is +5.0% vs its 50-day average ($0.90) and -7.0% vs its 200-day average ($1.02).
- 52-week range $0.68–$3.68; today's close sits at 9% of that range, 74.3% below the 52-week high.
Oct 7, 2026 — GDTC jumps 5.4% to $0.98
- Closed at $0.98, +5.38% vs the prior close of $0.93. Day range $0.80–$0.98, opened at $0.90.
- Volume was 15.20K shares, 0.5x its 50-day average of 28.95K — lighter than usual.
- Price is +9.0% vs its 50-day average ($0.90) and -3.8% vs its 200-day average ($1.02).
- 52-week range $0.68–$3.68; today's close sits at 10% of that range, 73.4% below the 52-week high.
Oct 6, 2026 — GDTC slides 7.9% to $0.93
- Closed at $0.93, -7.92% vs the prior close of $1.01. Day range $0.87–$0.95, opened at $0.95.
- Volume was 18.60K shares, 0.6x its 50-day average of 32.27K — lighter than usual.
- Price is +3.6% vs its 50-day average ($0.90) and -9.0% vs its 200-day average ($1.02).
- 52-week range $0.68–$3.68; today's close sits at 8% of that range, 74.7% below the 52-week high.
Oct 5, 2026 — GDTC jumps 9.8% to $1.01, a 1-month high, 3 up days in a row
- Closed at $1.01, +9.78% vs the prior close of $0.92. Day range $0.85–$1.06, opened at $0.85.
- Volume was 63.80K shares, 0.7x its 50-day average of 96.13K.
- Price is +12.6% vs its 50-day average ($0.90) and -1.5% vs its 200-day average ($1.03).
- 52-week range $0.68–$3.68; today's close sits at 11% of that range, 72.6% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — GDTC rises 2.2% to $0.92
- Closed at $0.92, +2.22% vs the prior close of $0.90. Day range $0.77–$0.92, opened at $0.80.
- Volume was 33.70K shares, 0.4x its 50-day average of 95.69K — lighter than usual.
- Price is +2.6% vs its 50-day average ($0.90) and -10.5% vs its 200-day average ($1.03).
- 52-week range $0.68–$3.68; today's close sits at 8% of that range, 75.0% below the 52-week high.
GDTC bull case vs bear case (from the data)
- Insiders made 20 open-market purchases in the last 12 months.
- Price is -5.0% vs its 50-day average — short-term trend is down.
- Price is -14.4% vs its 200-day average — below the long-term trend line.
- High volatility: average daily move of 4.4% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
GDTC latest news & SEC filings
Every SEC filing by or about GDTC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 14, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 14, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 24, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 20, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 14, 2026
- Choo Chee Kong bought 100,000 shares at $1.50 (≈$150.00K) on Jul 14, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade GDTC
- How much it moves: over the last 20 sessions the average daily move was 4.38% (largest 9.8%). That is a volatile stock.
- Liquidity: about 19.90K shares (≈$16.95K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.85 vs a range of $0.68–$3.68 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Chee Kong Choo bought 100,000 shares on Jul 20, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Sep 30, 2026; 6-K Jun 23, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GDTC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.85 | 0.87 | 0.84 | 0.85 | 15.00K |
| Oct 16, 2026 | 0.94 | 0.94 | 0.84 | 0.88 | 7.30K |
| Oct 15, 2026 | 0.81 | 0.88 | 0.73 | 0.87 | 9.50K |
| Oct 14, 2026 | 0.83 | 0.87 | 0.81 | 0.86 | 10.60K |
| Oct 13, 2026 | 0.87 | 0.88 | 0.81 | 0.87 | 24.00K |
| Oct 12, 2026 | 0.84 | 0.98 | 0.71 | 0.81 | 54.80K |
| Oct 9, 2026 | 0.94 | 0.94 | 0.85 | 0.89 | 11.80K |
| Oct 8, 2026 | 0.90 | 0.94 | 0.90 | 0.94 | 23.20K |
| Oct 7, 2026 | 0.90 | 0.98 | 0.80 | 0.98 | 15.20K |
| Oct 6, 2026 | 0.95 | 0.95 | 0.87 | 0.93 | 18.60K |
| Oct 5, 2026 | 0.85 | 1.06 | 0.85 | 1.01 | 63.80K |
| Oct 2, 2026 | 0.80 | 0.92 | 0.77 | 0.92 | 33.70K |
| Oct 1, 2026 | 0.84 | 0.90 | 0.84 | 0.90 | 6.40K |
| Sep 30, 2026 | 0.82 | 0.85 | 0.77 | 0.84 | 13.00K |
| Sep 29, 2026 | 0.85 | 0.89 | 0.81 | 0.89 | 25.40K |
| Sep 28, 2026 | 0.90 | 0.93 | 0.85 | 0.93 | 6.50K |
| Sep 25, 2026 | 0.91 | 0.95 | 0.88 | 0.95 | 11.80K |
| Sep 24, 2026 | 0.91 | 0.91 | 0.86 | 0.91 | 5.40K |
| Sep 23, 2026 | 0.88 | 0.91 | 0.87 | 0.91 | 9.70K |
| Sep 22, 2026 | 0.95 | 0.95 | 0.87 | 0.91 | 32.30K |
About CytoMed Therapeutics
CytoMed Therapeutics (GDTC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in 1 COMMONWEALTH LANE, Singapore. State of incorporation: Singapore. Fiscal year ends December 31. SEC CIK 1873093.
GDTC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chee Kong Choo | Director | Jul 24, 2026 |
| Mark Kei Wei Leong | Director | May 15, 2026 |
| Keng Kiat Toh | Director | May 26, 2026 |
| Chak Hua Yew | Director | May 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yvonne Goh | Chief Financial Officer | May 15, 2026 |
| Yoong Ying Tan | Chief Corporate Officer | May 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 20, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
| Jul 14, 2026 | Chee Kong Choo | Buy | 100,000 | $1.50 |
GDTC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GDTC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on GDTC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.